Revelstoke Capital Partners-backed Schryver Medical Sales and Marketing acquired B.O.N. Clinical Laboratories, which provides customized laboratory services to physicians. The acquisition is the fourth since January 2015 and Schryver’s first on the West Coast.
Schryver Medical Sales and Marketing, LLC (“Schryver”), a portfolio company of Revelstoke Capital Partners (“Revelstoke”), a Denver-based private equity firm, has completed the acquisition of B.O.N. Clinical Laboratories, Ltd. / Allstate Investment Realty, Inc. (“BON Labs”).
Schryver, headquartered in Denver, Colorado, is a JCAHO accredited provider of mobile imaging diagnostics, clinical laboratory services, oxygen therapy and durable medical equipment rental. Schryver serves nearly 3,000 long term post-acute facilities, assisted-living centers, and skilled nursing facilities, as well as numerous homecare patients. Schryver’s significant value proposition and service line diversity have resulted in long term customer relationships and a superior brand reputation. This acquisition marks the fourth since January 2015 and is Schryver’s first acquisition on the West Coast.
BON Labs, with laboratories in Las Vegas, NV, and Burbank, CA, provides customized laboratory services to physicians concerned with patient convenience, medically relevant testing, and current laboratory methodology. The laboratories are licensed with a CLIA High Complexity certification and are participating providers for Medicare, Medicaid, and MediCal insurance plans.
“We are excited to expand our operations in the Southwest,” said Doug Goetz, CEO of Schryver. “Rapid response times combined with the highest quality diagnostic services are critical to our customers, and adding BON’s significant resources allows us to better serve our current and new customers on the Pacific Coast. Importantly, Schryver will now be able to better serve these businesses in California through the acquisition of a MediCal lab number. This transaction serves as an important step in our continued effort to bring Schryver’s superior medical diagnostic services to this rapidly expanding industry across the U.S.”
“The resources, expertise, and strategy that Schryver has leveraged in building its reputation as a market leader will translate into continued success,” commented Mark King, CEO, Managing Partner and Co-Founder of Revelstoke. “We are pleased by the Schryver team’s continued ability to identify and integrate add-on opportunities.”
Perkins Coie LLP and Winston & Strawn LLP acted as legal advisors to Schryver.
Based in Denver, Colorado, and employing over 500 professionals, Schryver is a leading provider of mobile imaging, clinical laboratory, and oxygen therapy equipment outsourcing in the western United States serving the long term care market, hospitals, assisted-living centers, and homecare patients.
Revelstoke is a private equity firm formed by experienced investors who focus on building industry-leading companies. Revelstoke strives to partner with management teams to execute on a disciplined organic and acquisition strategy to build exceptional companies. Revelstoke’s Managing Partners, Mark King, Dale Meyer and Simon Bachleda, have completed over 100 platform and add-on acquisitions, representing over $5 billion of total enterprise value.